Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis

Annals of Neurology

Volumn 39, Issue 2, 1996, Pages 233-240

  Talbot, Pierre J ^a   Paquette, Jean Sébastien ^a   Ciurli, Cristina ^b   Antel, Jack P ^c   Ouellet, France ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN; MYELIN BASIC PROTEIN; VIRUS ANTIGEN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CROSS REACTION; DEMYELINATING DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; CELL LINE; CORONAVIRUS; CORONAVIRUS 229E, HUMAN; CROSS REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0030030561     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390213     Document Type: Article

References (43)

1. Ffrenchconstant C. Pathogenesis of multiple sclerosis. Lancet 1994;343:271-275
2. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis - a critical overview. Can J Neurol Sci 1993;20:17-29
3. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36:S15-S17
4. Steinman L, Oksenberg JR, Bernard CCA. Association of susceptibility to multiple sclerosis with TCR genes. Immunol Today 1992;13:49-51
5. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6:382-427
6. Talbor PJ. Implication of viruses in multiple sclerosis. Médecine/Sciences 1995;11:837-843
7. Myint SH. Human coronaviruses - a brief review. Rev Med Virol 1994;4:35-46
8. Murray RS, Cai GY, Hoek K, et al. Coronavirus infects and causes demyelination in primate central nervous system. Virology 1992;188:274-284
9. Tanaka R, Iwasaki Y, Koprowski HJ. Intracisternal virus-like particles in the brain of a multiple sclerosis patient. J Neurosci Res 1976;28:121-126
10. Burks JS, DeVald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980;209:933-934
11. Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982;32:292-295
12. Pearson J, Mims CA. Differential susceptibility of cultured neural cells to the human coronavirus OC43. J Virol 1985;53: 1016-1019
13. Talbot PJ, Ékandé S, Cashman NR, et al. Neurotropism of human coronavirus 229E. Adv Exp Med Biol 1994;32:339-346
14. Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 1992;191:502-505
15. Murray RS, Brown B, Brian D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 1992;31:525-533
16. Zhang JW, Markovicplese S, Lacet B, et al Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebro spinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-984
17. Sun JB, Link H, Olsson T, et al. T-cell and B-cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991;146:1490-1495
18. Zhang Y, Burger D, Saruhan G, et al. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology 1993;43: 403-407
19. Derosbo NK, Milo R, Lees MB, et al. Reactivity to myelin antigens in multiple sclerosis - peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993;92:2602-2608
20. Watanabe R, Wege H, ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 1983;305:150-153
21. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-820
22. Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. FASEB J 1992;6:840-844
23. Jahnke U, Fischer EH, Alvord EC. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985;229:282-284
24. Shaw SY, Laursen RA, Lees MB. Analogous amino acid sequences in myelin proteolipid and viral proteins. FEBS Lett 1986;207:266-270
25. Ota K, Matsui M, Milford EL, et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990;346:183-187
26. Jouvenne P, Mounir S, Stewart JN, et al. Sequence analysis of human coronavirus 229E messenger RNAs 4 and 5 - evidence for polymorphism and homology with myelin basic protein. Virus Res 1992;22:125-141
27. Cheifetz S, Moscarello MA. Effect of bovine basic protein charge microheterogeneity on protein-induced aggregation of unilamellar vesicles containing a mixture of acidic and neutral phospholipids Biochemistry 1983;24:1909-1914
28. Mounir S, Talbot PJ. Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation. J Gen Virol 1992;73:2731-2736
29. Pette M, Fujita K, Kitze MD, et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 1990;40:1770-1776
30. Richert JR, Reuben-Burnside CA, Deibler GE, Kies MW. Peptide specificities of myelin basic protein-reactive human T-cell clones. Neurology 1988;38:739-742
31. Inobe J-i, Yamamura T, Kunishita T, Tabira T. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients. J Neuroimmunol 1993;46:83-90
32. Labrecque N, McGrath H, Subramanyam M, et al. Human T cells respond to mouse mammary tumor virus encoded super-antigen - V-beta restriction and conserved evolutionary features. J Exp Med 1993;177:1735-1743
33. Matzinger P Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045
34. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 1994;179:1933-1943
35. Gautam AM, Lock CB, Smilek DE, et al. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules - implications in induction of autoimmunity. Proc Natl Acad Sci USA 1994;91:767-771
36. Wucherpfennig KW, Strominger JL. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705
37. Wucherpfennig KW, Sette A, Southwood S, et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-290
38. Riethmuller A, Kalbus M, Dubois E, et al. T-cell-reactivity against CNPase (a minor myelin component) in multiple sclerosis patients and normals. J Neuroimmunol 1994;54:191
39. van Noort JM, van Sechel AC, Bajramovic JJ, et al. The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995;375;798-801
40. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994;36:S25-S28
41. Duquette P, Girard M, Despault L, et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661
42. Paty DW, Li DKB, Duquette P, et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667
43. Jacobs L, Cookfair D, Rudick R, et al. Results of a phase III trial of IM recombinant beta interferon as treatment for MS. J Neuroimmunol 1994;54:170